Foundry Tang Factor ETF
ETF Foundry Research (hypothetical) · rebalanced monthly
Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.
Hypothetical growth of $1 — long-short backtest
Gross of the placeholder expense ratio and trading costs · not investor results
Holdings
Every constituent of the long leg — sort, search or filter by sector
| Ticker | Company | Sector | Market cap | Weight |
|---|---|---|---|---|
1MU | MICRON TECHNOLOGY INC | Technology | $958.80B | 31.01% |
2COST | COSTCO WHOLESALE CORP | Consumer Defensive | $417.26B | 13.50% |
3AXP | AMERICAN EXPRESS CO | Financial Services | $242.46B | 7.84% |
4SCCO | SOUTHERN COPPER CORP | Basic Materials | $142.48B | 4.61% |
5BKNG | BOOKING HOLDINGS INC | Industrials | $140.78B | 4.55% |
6HOOD | ROBINHOOD MARKETS INC | Financial Services | $90.01B | 2.91% |
7ROST | ROSS STORES INC | Consumer Cyclical | $74.89B | 2.42% |
8BE | BLOOM ENERGY CORP | Industrials | $61.14B | 1.98% |
9CBRS | CEREBRAS SYSTEMS INC | Technology | $39.16B | 1.27% |
10NTRA | NATERA INC | Healthcare | $38.87B | 1.26% |
11CRDO | CREDO TECHNOLOGY GROUP HOLDING LTD | Technology | $37.80B | 1.22% |
12ONC | BEONE MEDICINES LTD | Healthcare | $34.68B | 1.12% |
13CPNG | COUPANG INC | Consumer Cyclical | $29.83B | 0.96% |
14CPRT | COPART INC | Industrials | $25.56B | 0.83% |
15SYM | SYMBOTIC INC | Industrials | $24.86B | 0.80% |
16EXPD | EXPEDITORS INTERNATIONAL OF WASHINGTON INC | Industrials | $23.91B | 0.77% |
17INCY | INCYTE CORP | Healthcare | $23.42B | 0.76% |
18ASTS | AST SPACEMOBILE INC | Technology | $22.43B | 0.73% |
19GH | GUARDANT HEALTH INC | Healthcare | $20.67B | 0.67% |
20BBIO | BRIDGEBIO PHARMA INC | Healthcare | $15.94B | 0.52% |
21CRCL | CIRCLE INTERNET GROUP INC | Financial Services | $15.03B | 0.49% |
22DECK | DECKERS OUTDOOR CORP | Consumer Cyclical | $14.79B | 0.48% |
23LOGI | LOGITECH INTERNATIONAL SA | Technology | $14.76B | 0.48% |
24SMCI | SUPER MICRO COMPUTER INC | Technology | $14.54B | 0.47% |
25MLI | MUELLER INDUSTRIES INC | Industrials | $13.08B | 0.42% |
26AXSM | AXSOME THERAPEUTICS INC | Healthcare | $11.84B | 0.38% |
27W | WAYFAIR INC | Consumer Cyclical | $11.79B | 0.38% |
28VICR | VICOR CORP | Technology | $10.83B | 0.35% |
29ARW | ARROW ELECTRONICS INC | Technology | $10.56B | 0.34% |
30GME | GAMESTOP CORP | Consumer Cyclical | $9.82B | 0.32% |
31WULF | TERAWULF INC | Financial Services | $9.00B | 0.29% |
32OSCR | OSCAR HEALTH INC | Healthcare | $8.77B | 0.28% |
33TTD | TRADE DESK INC | Technology | $8.74B | 0.28% |
34DDS | DILLARD'S INC | Consumer Cyclical | $8.61B | 0.28% |
35POWL | POWELL INDUSTRIES INC | Industrials | $8.48B | 0.27% |
36IMVT | IMMUNOVANT INC | Healthcare | $8.27B | 0.27% |
37AAOI | APPLIED OPTOELECTRONICS INC | Technology | $8.22B | 0.27% |
38MP | MP MATERIALS CORP | Basic Materials | $8.05B | 0.26% |
39JAN | JANUS LIVING INC | Industrials | $7.99B | 0.26% |
40APLD | APPLIED DIGITAL CORP | Financial Services | $7.37B | 0.24% |
41FRVO | FERVO ENERGY CO | Utilities | $7.26B | 0.23% |
42CIFR | CIPHER DIGITAL INC | Financial Services | $7.18B | 0.23% |
43LSTR | LANDSTAR SYSTEM INC | Industrials | $7.18B | 0.23% |
44OKLO | OKLO INC | Utilities | $7.15B | 0.23% |
45JOBY | JOBY AVIATION INC | Industrials | $7.11B | 0.23% |
46LQDA | LIQUIDIA CORP | Healthcare | $7.11B | 0.23% |
47CORZ | CORE SCIENTIFIC INC | Technology | $6.66B | 0.22% |
48SRRK | SCHOLAR ROCK HOLDING CORP | Healthcare | $6.33B | 0.20% |
49DUOL | DUOLINGO INC | Technology | $6.24B | 0.20% |
50CVLT | COMMVAULT SYSTEMS INC | Technology | $6.10B | 0.20% |
51MYRG | MYR GROUP INC | Industrials | $6.10B | 0.20% |
52BLLN | BILLIONTOONE INC | Healthcare | $5.99B | 0.19% |
53WFRD | WEATHERFORD INTERNATIONAL PLC | Energy | $5.80B | 0.19% |
54DAVE | DAVE INC | Technology | $5.60B | 0.18% |
55ACMR | ACM RESEARCH INC | Technology | $5.56B | 0.18% |
56TXG | 10X GENOMICS INC | Healthcare | $5.55B | 0.18% |
57KVYO | KLAVIYO INC | Technology | $5.29B | 0.17% |
58RELY | REMITLY GLOBAL INC | Technology | $5.08B | 0.16% |
59ANDG | ANDERSEN GROUP INC | Consumer Cyclical | $5.02B | 0.16% |
60PTRN | PATTERN GROUP INC | Consumer Cyclical | $4.97B | 0.16% |
61DFTX | DEFINIUM THERAPEUTICS INC | Healthcare | $4.83B | 0.16% |
62CAI | CARIS LIFE SCIENCES INC | Healthcare | $4.66B | 0.15% |
63UEC | URANIUM ENERGY CORP | Basic Materials | $4.59B | 0.15% |
64ALHC | ALIGNMENT HEALTHCARE INC | Healthcare | $4.26B | 0.14% |
65HHH | HOWARD HUGHES HOLDINGS INC | Real Estate | $4.19B | 0.14% |
66COCO | VITA COCO COMPANY INC | Consumer Defensive | $4.18B | 0.14% |
67TPC | TUTOR PERINI CORP | Industrials | $4.14B | 0.13% |
68CENX | CENTURY ALUMINUM CO | Basic Materials | $4.11B | 0.13% |
69BETA | BETA TECHNOLOGIES INC | Industrials | $4.10B | 0.13% |
70DYN | DYNE THERAPEUTICS INC | Healthcare | $3.92B | 0.13% |
71LASR | NLIGHT INC | Technology | $3.91B | 0.13% |
72LBRT | LIBERTY ENERGY INC | Energy | $3.89B | 0.13% |
73CPRX | CATALYST PHARMACEUTICALS INC | Healthcare | $3.85B | 0.12% |
74PAY | PAYMENTUS HOLDINGS INC | Technology | $3.75B | 0.12% |
75PBLS | PARABILIS MEDICINES INC | Healthcare | $3.51B | 0.11% |
76USAR | USA RARE EARTH INC | Basic Materials | $3.49B | 0.11% |
77WRBY | WARBY PARKER INC | Healthcare | $3.24B | 0.10% |
78AAP | ADVANCE AUTO PARTS INC | Consumer Cyclical | $3.19B | 0.10% |
79CRVL | CORVEL CORP | Financial Services | $3.13B | 0.10% |
80PENG | PENGUIN SOLUTIONS INC | Technology | $3.10B | 0.10% |
81LEU | CENTRUS ENERGY CORP | Basic Materials | $3.07B | 0.10% |
82USLM | UNITED STATES LIME & MINERALS INC | Basic Materials | $3.01B | 0.10% |
83XNDU | XANADU QUANTUM TECHNOLOGIES LTD | Technology | $2.98B | 0.10% |
84FIZZ | NATIONAL BEVERAGE CORP | Consumer Defensive | $2.91B | 0.09% |
85AVPT | AVEPOINT INC | Technology | $2.80B | 0.09% |
86FRPT | FRESHPET INC | Consumer Defensive | $2.78B | 0.09% |
87ESTA | ESTABLISHMENT LABS HOLDINGS INC | Healthcare | $2.72B | 0.09% |
88KOD | KODIAK SCIENCES INC | Healthcare | $2.67B | 0.09% |
89FLNC | FLUENCE ENERGY INC | Utilities | $2.59B | 0.08% |
90TMDX | TRANSMEDICS GROUP INC | Healthcare | $2.56B | 0.08% |
91PTON | PELOTON INTERACTIVE INC | Consumer Cyclical | $2.55B | 0.08% |
92IMNM | IMMUNOME INC | Healthcare | $2.53B | 0.08% |
93RUM | RUMBLE INC | Technology | $2.51B | 0.08% |
94BLBD | BLUE BIRD CORP | Consumer Cyclical | $2.48B | 0.08% |
95SLS | SELLAS LIFE SCIENCES GROUP INC | Healthcare | $2.45B | 0.08% |
96BCRX | BIOCRYST PHARMACEUTICALS INC | Healthcare | $2.36B | 0.08% |
97SLDE | SLIDE INSURANCE HOLDINGS INC | Financial Services | $2.35B | 0.08% |
98PLUS | EPLUS INC | Technology | $2.33B | 0.08% |
99BHVN | BIOHAVEN LTD | Healthcare | $2.32B | 0.08% |
100NG | NOVAGOLD RESOURCES INC | Basic Materials | $2.27B | 0.07% |
101PVLA | PALVELLA THERAPEUTICS INC | Healthcare | $2.26B | 0.07% |
102BKE | BUCKLE INC | Consumer Cyclical | $2.19B | 0.07% |
103MCRI | MONARCH CASINO & RESORT INC | Consumer Cyclical | $2.18B | 0.07% |
104AXGN | AXOGEN INC | Healthcare | $2.12B | 0.07% |
105PPTA | PERPETUA RESOURCES CORP | Basic Materials | $2.11B | 0.07% |
106SIND | SYNTHETIC INDUSTRIES INC | Consumer Cyclical | $2.03B | 0.07% |
107ADMA | ADMA BIOLOGICS INC | Healthcare | $2.02B | 0.07% |
108INOD | INNODATA INC | Technology | $1.99B | 0.06% |
109PLSE | PULSE BIOSCIENCES INC | Healthcare | $1.98B | 0.06% |
110AMLX | AMYLYX PHARMACEUTICALS INC | Healthcare | $1.97B | 0.06% |
111OCUL | OCULAR THERAPEUTIX INC | Healthcare | $1.96B | 0.06% |
112URGN | UROGEN PHARMA LTD | Healthcare | $1.96B | 0.06% |
113DMRA | DAMORA THERAPEUTICS INC | Healthcare | $1.94B | 0.06% |
114NSP | INSPERITY INC | Industrials | $1.89B | 0.06% |
115ZBIO | ZENAS BIOPHARMA INC | Healthcare | $1.86B | 0.06% |
116MQ | MARQETA INC | Technology | $1.85B | 0.06% |
117SSMR | SUNSHINE MINING & REFINING CO | Basic Materials | $1.83B | 0.06% |
118BCAX | BICARA THERAPEUTICS INC | Healthcare | $1.82B | 0.06% |
119LIND | LINDBLAD EXPEDITIONS HOLDINGS INC | Industrials | $1.81B | 0.06% |
120ALMR | ALAMAR BIOSCIENCES INC | Healthcare | $1.80B | 0.06% |
121RVLV | REVOLVE GROUP INC | Consumer Cyclical | $1.78B | 0.06% |
122LPG | DORIAN LPG LTD | Energy | $1.76B | 0.06% |
123HYMC | HYCROFT MINING HOLDING CORP | Basic Materials | $1.74B | 0.06% |
124BFLY | BUTTERFLY NETWORK INC | Healthcare | $1.73B | 0.06% |
125TSHA | TAYSHA GENE THERAPIES INC | Healthcare | $1.71B | 0.06% |
126IMKTA | INGLES MARKETS INC | Consumer Defensive | $1.71B | 0.06% |
127PLAB | PHOTRONICS INC | Technology | $1.70B | 0.06% |
128ANAB | ANAPTYSBIO INC | Healthcare | $1.69B | 0.05% |
129LIME | NEUTRON HOLDINGS INC | Technology | $1.68B | 0.05% |
130STDN | STANDARD NUCLEAR INC | Basic Materials | $1.67B | 0.05% |
131CMPS | COMPASS PATHWAYS PLC | Healthcare | $1.67B | 0.05% |
132PUMP | PROPETRO HOLDING CORP | Energy | $1.59B | 0.05% |
133IDT | IDT CORP | Communication Services | $1.57B | 0.05% |
134AMBQ | AMBIQ MICRO INC | Technology | $1.55B | 0.05% |
135XZO | EXZEO GROUP INC | Financial Services | $1.46B | 0.05% |
136VIA | VIA TRANSPORTATION INC | Technology | $1.46B | 0.05% |
137TRS | TRIMAS CORP | Consumer Cyclical | $1.46B | 0.05% |
138MLTX | MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | $1.45B | 0.05% |
139ARLO | ARLO TECHNOLOGIES INC | Basic Materials | $1.45B | 0.05% |
140AMPX | AMPRIUS TECHNOLOGIES INC | Industrials | $1.44B | 0.05% |
141HLX | HELIX ENERGY SOLUTIONS GROUP INC | Energy | $1.41B | 0.05% |
142OMDA | OMADA HEALTH INC | Healthcare | $1.41B | 0.05% |
143GCT | GIGACLOUD TECHNOLOGY INC | Technology | $1.40B | 0.05% |
144WINA | WINMARK CORP | Consumer Cyclical | $1.39B | 0.05% |
145REAL | THEREALREAL INC | Consumer Cyclical | $1.35B | 0.04% |
146BW | BABCOCK & WILCOX ENTERPRISES INC | Industrials | $1.35B | 0.04% |
147AKTS | AKTIS ONCOLOGY INC | Healthcare | $1.33B | 0.04% |
148PBT | PERMIAN BASIN ROYALTY TRUST | Energy | $1.32B | 0.04% |
149STAA | STAAR SURGICAL CO | Healthcare | $1.32B | 0.04% |
150DMLP | DORCHESTER MINERALS LP | Energy | $1.31B | 0.04% |
151NSSC | NAPCO SECURITY TECHNOLOGIES INC | Industrials | $1.29B | 0.04% |
152IE | IVANHOE ELECTRIC INC | Basic Materials | $1.29B | 0.04% |
153INBX | INHIBRX BIOSCIENCES INC | Healthcare | $1.28B | 0.04% |
154TRAX | FIRST TRACKS BIOTHERAPEUTICS INC | Unclassified | $1.27B | 0.04% |
155AVLN | AVALYN PHARMA INC | Healthcare | $1.25B | 0.04% |
156IRMD | IRADIMED CORP | Healthcare | $1.24B | 0.04% |
157LIFE | ETHOS TECHNOLOGIES INC | Financial Services | $1.17B | 0.04% |
158MGTX | MEIRAGTX HOLDINGS PLC | Healthcare | $1.15B | 0.04% |
159NUTX | NUTEX HEALTH INC | Healthcare | $1.12B | 0.04% |
160WVE | WAVE LIFE SCIENCES LTD | Healthcare | $1.12B | 0.04% |
161PRCT | PROCEPT BIOROBOTICS CORP | Healthcare | $1.09B | 0.04% |
162SHAZ | SHARONAI HOLDINGS INC | Technology | $1.07B | 0.03% |
163BIOA | BIOAGE LABS INC | Healthcare | $1.01B | 0.03% |
164FBRX | FORTE BIOSCIENCES INC | Healthcare | $1.00B | 0.03% |
165BBSI | BARRETT BUSINESS SERVICES INC | Industrials | $984M | 0.03% |
166ANRO | ALTO NEUROSCIENCE INC | Healthcare | $967M | 0.03% |
167LWLG | LIGHTWAVE LOGIC INC | Basic Materials | $960M | 0.03% |
168ANNX | ANNEXON INC | Healthcare | $950M | 0.03% |
169COUR | COURSERA INC | Consumer Defensive | $941M | 0.03% |
170RCAT | RED CAT HOLDINGS INC | Technology | $938M | 0.03% |
171APEI | AMERICAN PUBLIC EDUCATION INC | Consumer Defensive | $930M | 0.03% |
172EVER | EVERQUOTE INC | Communication Services | $925M | 0.03% |
173LBRX | LB PHARMACEUTICALS INC | Healthcare | $901M | 0.03% |
174TBN | TAMBORAN RESOURCES CORP | Energy | $890M | 0.03% |
175TBPH | THERAVANCE BIOPHARMA INC | Healthcare | $873M | 0.03% |
176PHAT | PHATHOM PHARMACEUTICALS INC | Healthcare | $873M | 0.03% |
177REPL | REPLIMUNE GROUP INC | Healthcare | $859M | 0.03% |
178SLDB | SOLID BIOSCIENCES INC | Healthcare | $859M | 0.03% |
179AVR | ANTERIS TECHNOLOGIES GLOBAL CORP | Healthcare | $823M | 0.03% |
180UMAC | UNUSUAL MACHINES INC | Industrials | $809M | 0.03% |
181MTUS | METALLUS INC | Basic Materials | $807M | 0.03% |
182OFRM | ONCE UPON A FARM PBC | Consumer Defensive | $761M | 0.02% |
183KRT | KARAT PACKAGING INC | Consumer Cyclical | $760M | 0.02% |
184METC | RAMACO RESOURCES INC | Basic Materials | $760M | 0.02% |
185DSP | VIANT TECHNOLOGY INC | Technology | $754M | 0.02% |
186CADL | CANDEL THERAPEUTICS INC | Healthcare | $746M | 0.02% |
187IBTA | IBOTTA INC | Technology | $734M | 0.02% |
188AURA | AURA BIOSCIENCES INC | Healthcare | $723M | 0.02% |
189MAMA | MAMA'S CREATIONS INC | Consumer Defensive | $700M | 0.02% |
190PKE | PARK AEROSPACE CORP | Industrials | $677M | 0.02% |
191WHK | WHITEHAWK MINERALS CORP | Energy | $668M | 0.02% |
192SGP | SPYGLASS PHARMA INC | Healthcare | $661M | 0.02% |
193MNTN | MNTN INC | Technology | $661M | 0.02% |
194ACHV | ACHIEVE LIFE SCIENCES INC | Healthcare | $644M | 0.02% |
195FISN | DEEP FISSION INC | Industrials | $643M | 0.02% |
196TECX | TECTONIC THERAPEUTIC INC | Healthcare | $615M | 0.02% |
197FAC | FACTORIAL ENERGY INC | Industrials | $610M | 0.02% |
198PUBM | PUBMATIC INC | Technology | $591M | 0.02% |
199STTK | SHATTUCK LABS INC | Healthcare | $577M | 0.02% |
200MLR | MILLER INDUSTRIES INC | Consumer Cyclical | $566M | 0.02% |
201IMMX | IMMIX BIOPHARMA INC | Healthcare | $558M | 0.02% |
202ELA | ENVELA CORP | Consumer Cyclical | $547M | 0.02% |
203ALOY | REALLOYS INC | Basic Materials | $544M | 0.02% |
204CTRN | CITI TRENDS INC | Consumer Cyclical | $535M | 0.02% |
205TOI | ONCOLOGY INSTITUTE INC | Healthcare | $535M | 0.02% |
206VSTM | VERASTEM INC | Healthcare | $530M | 0.02% |
207EROC | EAGLE ROCK ENERGY PARTNERS L P | Energy | $520M | 0.02% |
208ZURA | ZURA BIO LTD | Healthcare | $518M | 0.02% |
209NVCT | NUVECTIS PHARMA INC | Healthcare | $508M | 0.02% |
210AIAI | AIAI HOLDINGS CORP | Industrials | $492M | 0.02% |
211JOUT | JOHNSON OUTDOORS INC | Consumer Cyclical | $485M | 0.02% |
212GDYN | GRID DYNAMICS HOLDINGS INC | Technology | $484M | 0.02% |
213CLMB | CLIMB GLOBAL SOLUTIONS INC | Technology | $482M | 0.02% |
214PAYS | PAYSIGN INC | Technology | $478M | 0.02% |
215CWCO | CONSOLIDATED WATER CO LTD | Utilities | $467M | 0.02% |
216FRPH | FRP HOLDINGS INC | Real Estate | $461M | 0.01% |
217CLPT | CLEARPOINT NEURO INC | Healthcare | $454M | 0.01% |
218PRTA | PROTHENA CORP PUBLIC LTD CO | Healthcare | $453M | 0.01% |
219BNTC | BENITEC BIOPHARMA INC | Healthcare | $439M | 0.01% |
220ASPN | ASPEN AEROGELS INC | Basic Materials | $425M | 0.01% |
221TENX | TENAX THERAPEUTICS INC | Healthcare | $420M | 0.01% |
222SWMR | SWARMER INC | Technology | $410M | 0.01% |
223CBIO | CRESCENT BIOPHARMA INC | Healthcare | $407M | 0.01% |
224MOBI | MOBIA MEDICAL INC | Healthcare | $404M | 0.01% |
225NATH | NATHANS FAMOUS INC | Consumer Cyclical | $393M | 0.01% |
226FLXS | FLEXSTEEL INDUSTRIES INC | Consumer Cyclical | $391M | 0.01% |
227GNE | GENIE ENERGY LTD | Utilities | $369M | 0.01% |
228FENC | FENNEC PHARMACEUTICALS INC | Healthcare | $365M | 0.01% |
229NATR | NATURES SUNSHINE PRODUCTS INC | Consumer Defensive | $359M | 0.01% |
230ELMD | ELECTROMED INC | Healthcare | $349M | 0.01% |
231STRT | STRATTEC SECURITY CORP | Consumer Cyclical | $344M | 0.01% |
232MTRX | MATRIX SERVICE CO | Industrials | $342M | 0.01% |
233MRAM | EVERSPIN TECHNOLOGIES INC | Technology | $341M | 0.01% |
234CV | CAPSOVISION INC | Healthcare | $335M | 0.01% |
235SEG | SEAPORT ENTERTAINMENT GROUP INC | Real Estate | $332M | 0.01% |
236CEPL | CAPSTONE ENERGY PLUS INC | Industrials | $329M | 0.01% |
237RTAC | RENATUS TACTICAL ACQUISITION CORP I | Industrials | $329M | 0.01% |
238MPTI | M-TRON INDUSTRIES INC | Technology | $328M | 0.01% |
239MSB | MESABI TRUST | Basic Materials | $320M | 0.01% |
240CARL | CARLSMED INC | Healthcare | $317M | 0.01% |
241HBB | HAMILTON BEACH BRANDS HOLDING CO | Consumer Cyclical | $313M | 0.01% |
242OSS | ONE STOP SYSTEMS INC | Technology | $313M | 0.01% |
243CIX | COMPX INTERNATIONAL INC | Industrials | $309M | 0.01% |
244BKTI | BK TECHNOLOGIES CORP | Technology | $307M | 0.01% |
245ALCO | ALICO INC | Consumer Defensive | $304M | 0.01% |
246OPTX | SYNTEC OPTICS HOLDINGS INC | Technology | $302M | 0.01% |
247OFLX | OMEGA FLEX INC | Industrials | $302M | 0.01% |
248KPET | KPET ULTRA PACELINE CORP | Industrials | $289M | 0.01% |
249UCFI | CN HEALTHY FOOD TECH GROUP CORP | Consumer Defensive | $288M | 0.01% |
250TSSI | TSS INC | Technology | $274M | 0.01% |
251SGHT | SIGHT SCIENCES INC | Healthcare | $274M | 0.01% |
252TTRX | TURN THERAPEUTICS INC | Healthcare | $272M | 0.01% |
253CEPO | CANTOR EQUITY PARTNERS I INC | Industrials | $271M | 0.01% |
254ALMU | AELUMA INC | Technology | $267M | 0.01% |
255CNXU | CONEXEU SCIENCES INC | Healthcare | $263M | 0.01% |
256TBI | TRUEBLUE INC | Industrials | $258M | 0.01% |
257LTBR | LIGHTBRIDGE CORP | Industrials | $256M | 0.01% |
258QTTB | Q32 BIO INC | Healthcare | $255M | 0.01% |
259SRZN | SURROZEN INC | Healthcare | $255M | 0.01% |
260VNME | VENDOME ACQUISITION CORP I | Industrials | $254M | 0.01% |
261RELL | RICHARDSON ELECTRONICS LTD | Technology | $250M | 0.01% |
262FRD | FRIEDMAN INDUSTRIES INC | Basic Materials | $242M | 0.01% |
263ASYS | AMTECH SYSTEMS INC | Technology | $242M | 0.01% |
264SOCA | SOLARIUS CAPITAL ACQUISITION CORP | Industrials | $241M | 0.01% |
265GLSI | GREENWICH LIFESCIENCES INC | Healthcare | $240M | 0.01% |
266USAU | US GOLD CORP | Basic Materials | $235M | 0.01% |
267UTMD | UTAH MEDICAL PRODUCTS INC | Healthcare | $222M | 0.01% |
268REA | RARE EARTHS AMERICAS INC | Basic Materials | $220M | 0.01% |
269KPTI | KARYOPHARM THERAPEUTICS INC | Healthcare | $216M | 0.01% |
270SMHI | SEACOR MARINE HOLDINGS INC | Industrials | $214M | 0.01% |
271KROS | KEROS THERAPEUTICS INC | Healthcare | $211M | 0.01% |
272GSIT | GSI TECHNOLOGY INC | Technology | $208M | 0.01% |
273RNA | ATRIUM THERAPEUTICS INC | Healthcare | $208M | 0.01% |
274PPIH | PERMA-PIPE INTERNATIONAL HOLDINGS INC | Basic Materials | $207M | 0.01% |
275IMUX | IMMUNIC INC | Healthcare | $207M | 0.01% |
276FOCL | FOCAL INC | Healthcare | $204M | 0.01% |
277DTIL | PRECISION BIOSCIENCES INC | Healthcare | $203M | 0.01% |
278ANIK | ANIKA THERAPEUTICS INC | Healthcare | $203M | 0.01% |
279AMWL | AMERICAN WELL CORP | Healthcare | $199M | 0.01% |
280TNXP | TONIX PHARMACEUTICALS HOLDING CORP | Healthcare | $198M | 0.01% |
281CPSS | CONSUMER PORTFOLIO SERVICES INC | Financial Services | $197M | 0.01% |
282ACOG | ALPHA COGNITION INC | Healthcare | $185M | 0.01% |
283SBMT | SILVER BOW MINING CORP | Basic Materials | $185M | 0.01% |
284EGAN | EGAIN CORP | Technology | $180M | 0.01% |
285KVHI | KVH INDUSTRIES INC | Technology | $178M | 0.01% |
286ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC | Healthcare | $172M | 0.01% |
287NLOP | NET LEASE OFFICE PROPERTIES | Real Estate | $172M | 0.01% |
288NUCL | EAGLE NUCLEAR ENERGY CORP | Basic Materials | $166M | 0.01% |
289OWLT | OWLET INC | Healthcare | $162M | 0.01% |
290LGCY | LEGACY EDUCATION INC | Consumer Defensive | $154M | 0.00% |
291SMID | SMITH MIDLAND CORP | Basic Materials | $152M | 0.00% |
292UNCY | UNICYCIVE THERAPEUTICS INC | Healthcare | $144M | 0.00% |
293HURC | HURCO COMPANIES INC | Industrials | $142M | 0.00% |
294ACNT | ASCENT INDUSTRIES CO | Basic Materials | $138M | 0.00% |
295PMN | PROMIS NEUROSCIENCES INC | Healthcare | $136M | 0.00% |
296AXR | AMREP CORP | Real Estate | $136M | 0.00% |
297FIRY | FIRY INC | Technology | $130M | 0.00% |
298VTVT | VTV THERAPEUTICS INC | Healthcare | $130M | 0.00% |
299AARD | AARDVARK THERAPEUTICS INC | Healthcare | $128M | 0.00% |
300CUE | CUE BIOPHARMA INC | Healthcare | $126M | 0.00% |
301BUDA | BUDA JUICE INC | Unclassified | $121M | 0.00% |
302SPRB | SPRUCE BIOSCIENCES INC | Healthcare | $120M | 0.00% |
303WYY | WIDEPOINT CORP | Technology | $115M | 0.00% |
304AMCI | AMC ROBOTICS CORP | Technology | $114M | 0.00% |
305CODA | CODA OCTOPUS GROUP INC | Industrials | $113M | 0.00% |
306USGO | US GOLDMINING INC | Basic Materials | $109M | 0.00% |
307TRT | TRIO-TECH INTERNATIONAL | Technology | $103M | 0.00% |
308ICCC | IMMUCELL CORP | Healthcare | $101M | 0.00% |
309ROC | RANK ONE COMPUTING CORP | Technology | $98M | 0.00% |
310VRCA | VERRICA PHARMACEUTICALS INC | Healthcare | $96M | 0.00% |
311LIXT | LIXTE BIOTECHNOLOGY HOLDINGS INC | Healthcare | $91M | 0.00% |
312OPXS | OPTEX SYSTEMS HOLDINGS INC | Industrials | $89M | 0.00% |
313RLYB | RALLYBIO CORP | Healthcare | $87M | 0.00% |
314CSBR | CHAMPIONS ONCOLOGY INC | Healthcare | $85M | 0.00% |
315IOR | INCOME OPPORTUNITY REALTY INVESTORS INC | Financial Services | $84M | 0.00% |
316INTG | INTERGROUP CORP | Consumer Cyclical | $84M | 0.00% |
317NRXS | NEURAXIS INC | Healthcare | $84M | 0.00% |
318WATT | ENERGOUS CORP | Technology | $83M | 0.00% |
319BDL | FLANIGANS ENTERPRISES INC | Consumer Cyclical | $76M | 0.00% |
320ROLR | HIGH ROLLER TECHNOLOGIES INC | Consumer Cyclical | $76M | 0.00% |
321ATRA | ATARA BIOTHERAPEUTICS INC | Healthcare | $76M | 0.00% |
322NMAD | NOMAD POWER SOLUTIONS INC | Healthcare | $72M | 0.00% |
323EDSA | EDESA BIOTECH INC | Healthcare | $59M | 0.00% |
324TACT | TRANSACT TECHNOLOGIES INC | Technology | $54M | 0.00% |
325INKT | MINK THERAPEUTICS INC | Healthcare | $53M | 0.00% |
326XLO | XILIO THERAPEUTICS INC | Healthcare | $53M | 0.00% |
327APT | ALPHA PRO TECH LTD | Basic Materials | $53M | 0.00% |
328MCRB | SERES THERAPEUTICS INC | Healthcare | $52M | 0.00% |
329EXOZ | EXOZYMES INC | Healthcare | $51M | 0.00% |
Full long-leg book as of July 2026 · cap-weighted · total market cap $3.09T. Hypothetical model holdings — not a registered fund’s portfolio.
Sector Breakdown
Portfolio Style
Size × value map of the long-leg book
Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 95% toward Large, 70% toward Growth. +5% unclassified (42 missing size/value). Hypothetical holdings — descriptive, not realized P&L.
Capital-weighted centroid of the long leg, December 1998 → July 2026; the right-hand end is the same value as the box’s dot. 329 names now. Hypothetical holdings — descriptive, not P&L.
Constraint checks
How this book measures against the concentration and liquidity rules — as implemented here
These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.
7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.
2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.
With respect to 75% of total assets, no more than 5% may be invested in the securities of any one issuer.
Required>= 75.0%Actual62.6%Margin-12.4%No more than 25% of total assets may be invested in the securities of any one issuer.
Required<= 25.0%Actual31.0%Margin-6.0%The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).
Required<= 25.0%Actual33.3%Margin-8.3%Days required to liquidate the largest position at 20% of one day's dollar volume.
Required<= 7.0 daysActualunboundedMargin—
Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.
No verdict sits within 1.0pp of its limit.
Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700
Measured on the 2026-07 formation date across 329 holdings (cap-weighted). A different formation date can produce different verdicts.
Derivatives risk (Rule 18f-4)
Whether this long-only book is subject to the VaR tests at all
This assessment describes the long-only book this fund holds — the top bucket only.
This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.
Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.
No confidence interval: this follows from portfolio construction, not from an estimate.
Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.
Informational — does not governThis fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.
historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months
The estimators disagree about the verdict, not just the value — the choice of method decides the answer here. Historical VaR gives ratio 2.06 (fail) but Gaussian VaR gives 1.82 (pass). The pass/fail conclusion is an artefact of estimator choice, not a property of the strategy.
Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.
The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.
See the long-short verdict on the factor page →Since publication
Did the edge survive the paper coming out?
Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.
Consistency across eras
Is this record broadly durable, or one regime?
3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.
Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.
Returns
Long leg is what this fund holds — long-short is shown for reference
| Period | Long leg | Long-short |
|---|---|---|
| 1 yearcum. | 18.6% | 25.9% |
| 3 yearsp.a. | 13.2% | 1.6% |
| 5 yearsp.a. | -8.8% | -16.4% |
| 10 yearsp.a. | 8.0% | -1.8% |
| Since inceptionp.a. | 4.6% | -1.4% |
| Year | Long leg | Long-short |
|---|---|---|
| 20267 mo | 11.9% | 9.3% |
| 2025 | 14.1% | 13.2% |
| 2024 | 9.4% | -8.8% |
| 2023 | 39.4% | 18.1% |
| 2022 | -56.5% | -57.1% |
| 2021 | -30.0% | -44.6% |
| 2020 | 113.7% | 133.5% |
| 2019 | 35.7% | 5.5% |
| 2018 | -5.5% | 7.3% |
| 2017 | 24.3% | 12.1% |
| 2016 | 6.6% | -9.6% |
| 2015 | -7.1% | -7.6% |
| 2014 | -0.6% | -8.2% |
| 2013 | 37.8% | -3.3% |
| 2012 | 12.3% | -7.9% |
| 2011 | -4.8% | 6.0% |
| 2010 | 33.2% | 14.5% |
| 2009 | 45.8% | 53.2% |
| 2008 | -42.6% | -19.5% |
| 2007 | 6.9% | 33.6% |
| 2006 | 9.8% | -4.6% |
| 2005 | 14.9% | 11.5% |
| 2004 | 10.8% | -4.3% |
| 2003 | 51.9% | 14.1% |
| 2002 | -34.7% | -32.1% |
| 2001 | -37.5% | -31.6% |
| 2000 | -42.0% | -54.5% |
| 1999 | 97.8% | 115.1% |
Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.
Fund Facts
Methodology
The Foundry Tang Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks (price > $5, market-cap floor) each month by a Tang signal and holds the top decile with the highest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.
This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.
Documents (draft — hypothetical)
Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.
Objective, fees, strategy, and key risks.
Full strategy, model methodology, and risks.
Policies, construction, and governance.
One-page snapshot with top holdings.
Full current constituent list.
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.